Opportunities to identify cures for cancer and other diseases, as well as jobs and a chance to maintain global competitiveness have already been lost to the sequester, panelists said at a recent Research!America forum. "That is research that could have been the next cure for cancer or the next Nobel Prize. But we'll never know," NIH Director Francis Collins said. The sequester has reduced and strained resources at the FDA and CDC, threatening public health and slowing innovation, agency directors said.
Published in Brief: